Lightning Round: Sarepta Therapeutics, Splunk, Sony and More

Franco-Nevada : Jim Cramer called this stock a "winner."

Sarepta Therapeutics : Cramer likes this stock right now, but only on a speculative basis.

Splunk : The "Mad Money" host can't recommend this stock right now.

Boardwalk Pipeline Partners : This is one of Cramer's favorite master limited partnerships in the pipeline space.

Under Armour : While this company is doing good, Cramer noted it's chart is doing bad.

Sony : This is one bad stock that lacks a catalyst to push higher, Cramer said.




@MadMoneyOnCNBC on Twitter

"Mad Money" on Facebook

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com